271 related articles for article (PubMed ID: 27463969)
1. Prevention of Cervix Cancer in India.
Mishra GA; Pimple SA; Shastri SS
Oncology; 2016; 91 Suppl 1():1-7. PubMed ID: 27463969
[TBL] [Abstract][Full Text] [Related]
2. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
3. The next steps in cervical screening.
Sankaranarayanan R; Qiao YL; Keita N
Womens Health (Lond); 2015 Mar; 11(2):201-12. PubMed ID: 25776294
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
5. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
6. The present scenario of cervical cancer control and HPV epidemiology in India: an outline.
Senapathy JG; Umadevi P; Kannika PS
Asian Pac J Cancer Prev; 2011; 12(5):1107-15. PubMed ID: 21875253
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening in low- and middle-income countries.
Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M
Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer control in Latin America: A call to action.
Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
[TBL] [Abstract][Full Text] [Related]
11. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
13. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
Almonte M; Sasieni P; Cuzick J
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India.
Basu P; Mittal S; Banerjee D; Singh P; Panda C; Dutta S; Mandal R; Das P; Biswas J; Muwonge R; Sankaranarayanan R
Int J Cancer; 2015 Aug; 137(4):859-67. PubMed ID: 25631198
[TBL] [Abstract][Full Text] [Related]
15. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer prevention & the role of human papillomavirus vaccines in India.
Bhatla N; Joseph E
Indian J Med Res; 2009 Sep; 130(3):334-40. PubMed ID: 19901443
[TBL] [Abstract][Full Text] [Related]
17. HPV vaccination: The most pragmatic cervical cancer primary prevention strategy.
Sankaranarayanan R
Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 1():S33-5. PubMed ID: 26433502
[TBL] [Abstract][Full Text] [Related]
18. HPV testing and vaccination in Europe.
Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
[TBL] [Abstract][Full Text] [Related]
19. Screening for cervical cancer and human papilloma virus: Indian context.
Deodhar KK
Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]